Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Vanessa Nancy-Portebois"'
Autor:
Fabio Di Giacomo, Daniel Lewandowski, Eric Cabannes, Vanessa Nancy-Portebois, Maurice Petitou, Serge Fichelson, Paul-Henri Romeo
Publikováno v:
Haematologica, Vol 97, Iss 4 (2012)
Background Although mobilization of hematopoietic stem cells and hematopoietic progenitor cells can be achieved with a combination of granulocyte colony-stimulating factor and plerixafor (AMD3100), improving approaches for hematopoietic progenitor ce
Externí odkaz:
https://doaj.org/article/cfdac1e253bc48319043a2ff5533fc68
Autor:
Jeffry A. J. Wisse, Maurice Petitou, Vanessa Nancy-Portebois, D.G. Meuleman, Martin de Kort, Constant A. A. van Boeckel, Gerard M. T. Vogel, Vincent Motte, Guy Dubreucq
Publikováno v:
Thrombosis and Haemostasis, 102(5), 804-810. Schattauer GmbH
SummaryThe elucidation of the structure of the antithrombin binding sequence in heparin has given a large impulse to the rational design of heparin related drugs. De novo chemical synthesis of the corresponding pentasaccharide as well as simplified a
Autor:
Christophe Cans, Nathalie Amzallag, Manuela Argentini, Adam Telerman, David Allanic, Dino Moras, V. F. Shalak, Marc Mirande, Bruno Goud, Virginie Crible, Giusy Fiucci, Vanessa Nancy-Portebois, Brent Passer, Robert Amson, Rowena Tufino
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, 2011, 100 (24), pp.13892-13897. ⟨10.1073/pnas.2335950100⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2011, 100 (24), pp.13892-13897. ⟨10.1073/pnas.2335950100⟩
Proceedings of the National Academy of Sciences of the United States of America, 2011, 100 (24), pp.13892-13897. ⟨10.1073/pnas.2335950100⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2011, 100 (24), pp.13892-13897. ⟨10.1073/pnas.2335950100⟩
Recently, we demonstrated that the expression levels of the translationally controlled tumor protein (TCTP) were strongly down-regulated at the mRNA and protein levels during tumor reversion/suppression and by the activation of p53 and Siah-1. To bet
Autor:
Fabio Di Giacomo, Paul-Henri Romeo, Maurice Petitou, Serge Fichelson, Daniel Lewandowski, Eric Cabannes, Vanessa Nancy-Portebois
Publikováno v:
Haematologica. 97(4)
Background Although mobilization of hematopoietic stem cells and hematopoietic progenitor cells can be achieved with a combination of granulocyte colony-stimulating factor and plerixafor (AMD3100), improving approaches for hematopoietic progenitor ce
Autor:
Robert Amson, Véronique Bouvard, Marcel Tuynder, Stephanie Morchoisne, Christophe Cans, Aude Roborel de Climens, Sylvie Prieur, Vanessa Nancy-Portebois, Laurent Susini, Brent Passer, Nathalie Amzallag, Giusy Fiucci, Virginie Crible, Adam Telerman, Jean Dausset, Alexandra Lespagnol, Moshe Oren
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, 2003, 100 (5), pp.2284-2289. ⟨10.1073/pnas.0530298100⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2003, 100 (5), pp.2284-2289. ⟨10.1073/pnas.0530298100⟩
Proceedings of the National Academy of Sciences of the United States of America, 2003, 100 (5), pp.2284-2289. ⟨10.1073/pnas.0530298100⟩
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, 2003, 100 (5), pp.2284-2289. ⟨10.1073/pnas.0530298100⟩
The p53 tumor suppressor protein plays a crucial role in tumorigenesis by controlling cell-cycle progression and apoptosis. We have previously described a transcript designated tumor suppressor activated pathway-6 (TSAP6) that is up-regulated in the
Autor:
Vanessa Nancy-Portebois, Jean-François Mirjolet, Maurice Petitou, Eric Cabannes, Guillaume Serin
Publikováno v:
Cancer Research. 70:5459-5459
Background: Heparan sulphate (HS) containing proteoglycans regulate the activity of many proteins (growth factors, cytokines, adhesion molecules…) involved in pathologies like cancer, inflammation, cardiovascular, metabolic and neurodegenerative di